ClinConnect ClinConnect Logo
Search / Trial NCT07000500

INSIDE: Intervention in Nutritional Supplementation to Improve Cognitive Decline in Elderly.

Launched by MARIA PAÇO · May 24, 2025

Trial Information

Current as of July 26, 2025

Enrolling by invitation

Keywords

Cognitive Decline Mild Cognitive Impairment Aging Nutritional Supplementation

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Inclusion Criteria:
  • Community-dwelling adults aged 65 years or older Evidence of mild cognitive decline (score \< 26 on the Montreal Cognitive Assessment - MoCA) Ability to provide written informed consent Willingness and ability to comply with study procedures and attend scheduled evaluations
  • - Exclusion Criteria: Diagnosis of dementia or any neurodegenerative disease (e.g., Alzheimer's, Parkinson's) Epilepsy and neurologically related conditions Severe sensory deficits (e.g., profound visual or hearing impairment) that impair cognitive assessment Current use of cognitive-enhancing medications or supplements that cannot be discontinued History of allergy or intolerance to components of the nutritional supplement Unstable chronic medical conditions (e.g., uncontrolled diabetes, heart failure, renal insufficiency) Participation in another clinical trial in the previous 3 months

About Maria Paço

Maria Paço is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodologies, Maria Paço collaborates with leading research institutions and healthcare professionals to conduct high-quality clinical trials. The organization prioritizes ethical standards and patient safety, ensuring compliance with regulatory requirements while fostering a culture of transparency and collaboration. Through its efforts, Maria Paço aims to contribute significantly to the development of effective treatments and therapies that address unmet medical needs.

Locations

Vila Nova De Famalicão, Braga, Portugal

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported